Prodromal interventions for schizophrenia vulnerability: the risks of being “at risk”

Given the morbidity and difficulty of treating psychotic disorders, including schizophrenia, there has been a move toward identifying and treating adolescents and young adults who appear to be clinically at risk or “prodromal” to psychosis. The field now has greater specificity in identification, wi...

Full description

Saved in:
Bibliographic Details
Published in:Schizophrenia research 2005-03, Vol.73 (2), p.173-184
Main Authors: Corcoran, Cheryl, Malaspina, Dolores, Hercher, Laura
Format: Article
Language:English
Subjects:
Adult and adolescent clinical studies
Bioethics
Biological and medical sciences
Confidentiality
Ethics
Health Insurance Portability and Accountability Act
Humans
Medical sciences
Personal Autonomy
Prodrome
Psychology. Psychoanalysis. Psychiatry
Psychopathology. Psychiatry
Psychoses
Psychosis
Risk
Risk Factors
Schizophrenia
Schizophrenia - therapy
Stereotyping
Treatment
United States
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:Given the morbidity and difficulty of treating psychotic disorders, including schizophrenia, there has been a move toward identifying and treating adolescents and young adults who appear to be clinically at risk or “prodromal” to psychosis. The field now has greater specificity in identification, with rates of 40–50% conversion to frank psychosis within 1–2 years. There is further evidence that medications and other treatments may have some efficacy for “prodromal” patients, though with variable side effects. However, controversy remains about some of the inherent risks in prodromal research, such as medication exposure and stigma among false-positives. In this paper, we add to this discussion through an analysis of ethics in prodromal research from the more established field of predictive genetic testing. Issues are raised about the effects of information on patients, families, and institutions, as well as future insurability, the limits of confidentiality (as it relies on discretion of patients and families), the autonomy of minors with psychiatric symptoms, and even the risks for the true-positive patient.
ISSN:0920-9964
1573-2509
DOI:10.1016/j.schres.2004.05.021